Clinical Report: Mastering Myopia: Innovations and Future Directions

Overview

This report highlights the ongoing advancements in myopia management, including the effectiveness of specialty lenses and the emerging role of combination therapies. Innovations such as biosensor-embedded lenses and light-based therapies are also discussed as potential future directions.

Background

Myopia is a growing global concern, necessitating innovative management strategies to slow its progression. Current interventions include specialty lenses like orthokeratology and multifocal soft lenses, which have demonstrated efficacy. As research evolves, new approaches, including combination therapies and advanced technologies, may further enhance myopia management.

Data Highlights

No numerical data provided in the source material.

Key Findings

• Orthokeratology and soft multifocal lenses are effective in slowing myopia progression.
• Combination therapy with atropine and specialty lenses may enhance myopia control effectiveness.
• Emerging technologies include biosensor-embedded lenses for monitoring ocular health.
• Light-based therapies, such as red light therapy, show promise but have limitations regarding safety in children.
• Artificial intelligence may personalize myopia management through predictive algorithms based on biometric data.

Clinical Implications

Clinicians should consider integrating combination therapies, such as atropine with specialty lenses, into treatment plans for young myopes. Staying updated on emerging technologies and their potential applications in myopia management is crucial for optimizing patient outcomes.

Conclusion

The future of myopia management is poised for significant advancements through innovative therapies and technologies. Continued research and clinical application will be essential in refining these strategies.

References

1. Wildsoet CF, et al., Invest Ophthalmol Vis Sci, 2019 -- IMI - interventions for controlling myopia onset and progression report
2. Zhang XJ, et al., Ophthalmology, 2024 -- Five-year clinical trial of the low-concentration atropine for myopia progression (LAMP) study: phase 4 report
3. Tsai HR, et al., J Formos Med Assoc, 2022 -- Efficacy of atropine, orthokeratology, and combined atropine with orthokeratology for childhood myopia
4. Liu X, et al., ACS Nano, 2024 -- Smart contact lenses for healthcare monitoring and therapy
5. Xu Y, et al., Ophthalmology, 2024 -- Repeated low-level red light therapy for myopia control in high myopia children and adolescents
6. Zhang J, Zou H, Graefes Arch Clin Exp Ophthalmol, 2024 -- Insights into artificial intelligence in myopia management: from a data perspective
7. contact lens spectrum — Mastering Myopia
8. Contact Lens Spectrum — MASTERING MYOPIA
9. Contact Lens Spectrum — MASTERING MYOPIA
10. contact lens spectrum — Mastering Myopia: Starting Strong: Managing Myopia from the Onset
11. Mastering Myopia
12. IMI - Interventions for Controlling Myopia Onset and Progression
13. Orthokeratology, 0.04% Atropine, and 0.01% Atropine for Myopia Control: A Randomized Clinical Trial | Trials | JAMA Ophthalmology | JAMA Network
14. Is Spending More Time Outdoors Able to Prevent and Control Myopia in Children and Adolescents? A Meta-Analysis - PubMed